What is standing in the way of global access to cell and gene therapies? At Advanced Therapies Week 2025, Autolomous CEO, Alexander Seyf, joined Carol Houts (CCO of Germfree) for a fireside chat to discuss Act for Hope—a transformative initiative dedicated to democratizing advanced medicine.